Publications
Detailed Information
Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Moon, Hongran | - |
dc.contributor.author | Chin, Ho Jun | - |
dc.contributor.author | Na, Ki Young | - |
dc.contributor.author | Joo, Kwon Wook | - |
dc.contributor.author | Kim, Yon Su | - |
dc.contributor.author | Kim, Sejoong | - |
dc.contributor.author | Han, Seung Seok | - |
dc.date.accessioned | 2019-11-11T00:56:09Z | - |
dc.date.available | 2019-11-11T09:57:09Z | - |
dc.date.issued | 2019-09-18 | - |
dc.identifier.citation | BMC Nephrology, 20(1):362 | ko_KR |
dc.identifier.issn | 1471-2369 | - |
dc.identifier.uri | https://hdl.handle.net/10371/162648 | - |
dc.description.abstract | Background
Hyperphosphatemia is associated with vascular calcification and bone mineral disorders and is a major concern among patients with chronic kidney disease (CKD). However, the relationship between hyperphosphatemia and renal outcome in non-CKD patients has not been studied. Furthermore, the clinical implications of hyperphosphatemia in relation to the risks of acute kidney injury (AKI), end-stage renal disease (ESRD), and mortality after hospitalization remain unresolved. Methods A total of 20,686 patients (aged ≥18 years) admitted to Seoul National University Bundang Hospital from January 2013 to December 2013 were retrospectively reviewed. Patients were divided into quartiles according to serum phosphorus level at the time of admission. The odds ratios (ORs) for AKI and hazard ratios (HRs) for ESRD and all-cause mortality were calculated after adjustment of multiple covariates. Results AKI developed in 2319 patients (11.2%), with higher ORs for patients in the third and fourth quartiles (1.4 [1.24–1.68] and 2.8 [2.44–3.22], respectively) compared with the first quartile group. During a median follow-up period of 4.0 years, 183 patients (0.88%) developed ESRD and 3675 patients (17.8%) died. Patients in the fourth quartile had higher risks of ESRD and mortality than patients in the first quartile (HRs, 2.3 [1.46–3.75] and 1.4 [1.22–1.49], respectively). These trends remained consistent in patients with an estimated glomerular filtration rate > 60 ml/min/1.73 m2. Conclusions Hyperphosphatemia is related to the risks of AKI, ESRD, and mortality, and it may therefore be necessary to monitor serum phosphorus level in hospitalized patients, irrespective of kidney function. | ko_KR |
dc.description.sponsorship | This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1B03031642 to S.S. Han) and the grant from the NRF (2017R1A2B4005251 to S. Kim), which had no role in the study design,
data collection, analysis, interpretation, or writing of the manuscript. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.subject | Acute kidney injury | ko_KR |
dc.subject | End-stage renal disease | ko_KR |
dc.subject | Hyperphosphatemia | ko_KR |
dc.subject | Mortality | ko_KR |
dc.subject | Phosphorus | ko_KR |
dc.title | Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 문홍란 | - |
dc.contributor.AlternativeAuthor | 진호준 | - |
dc.contributor.AlternativeAuthor | 나기영 | - |
dc.contributor.AlternativeAuthor | 주권욱 | - |
dc.contributor.AlternativeAuthor | 김연수 | - |
dc.contributor.AlternativeAuthor | 김세중 | - |
dc.contributor.AlternativeAuthor | 한승석 | - |
dc.identifier.doi | 10.1186/s12882-019-1556-y | - |
dc.rights.holder | The Author(s). | - |
dc.date.updated | 2019-09-22T03:35:11Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.